Riskpilot← Back to searchSign inGet full accessDoremed Oy
OYActiveY-tunnus 2892249-6As. 20Medical specialists activities · NACE 8622Est. 20181 employees
Revenue 2025
EUR 145K
+6% vs 2024
EBITDA margin
—
Equity ratio
97.6%
Financial strength
Net profit 2025
EUR 19
+101% vs 2024
| Revenue | EUR 145K | +6% |
| EBITDA | — | — |
| Net profit | EUR 19 | +101% |
| Total assets | EUR 105K | -12% |
| Equity | EUR 103K | -13% |
| Employees | 1 | — |
Legal name
Doremed Oy
Y-tunnus number
2892249-6
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
11. helmikuuta 2018
Share capital
EUR 2 500
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Company purpose
Lääkäripalvelut, valokuvaus ja kaikki muu laillinen liiketoiminta.
Address
As. 20
Phone
+3580443548569
Email
harriet.honkaniemi@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | 147 | 154 | 146 | 154 | 145 | 137 | 145 |
| Staff expenses | −92 | −100 | −98 | −79 | −35 | −55 | −77 |
| EBITDA | 41 | 38 | 22 | 38 | 52 | 7 | — |
| Depreciation & amort. | −1 | −0 | −0 | −1 | −7 | −8 | −6 |
| EBIT | 41 | 38 | 22 | 36 | 45 | −1 | −7 |
| Net financials | −0 | −0 | −0 | −0 | 0 | −0 | — |
| Profit before tax | 41 | 38 | 22 | 36 | 45 | −1 | — |
| Tax | 8 | 2 | 10 | 7 | 9 | −0 | −7 |
| Net profit | 33 | 36 | 12 | 29 | 36 | −1 | 0 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Total assets | 46 | 83 | 88 | 105 | 136 | 120 | 105 |
| Equity | 42 | 74 | 80 | 103 | 130 | 118 | 103 |
| Long-term debt | — | — | — | — | 0 | 0 | 0 |
| Short-term debt | 4 | 9 | 8 | 2 | 6 | 1 | 3 |
| Total debt | 4 | 9 | 8 | 2 | 6 | 1 | 3 |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20192025
Equity ratio
97.6%
This company
38.2%
Market median
+155% vs market
20192025
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20192025
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20192025
Asset turnover
1.38×
This company
1.12×
Market median
+23% vs market
20192025
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20192025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via PRH / YTJ · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JE Deputy Member | Deputy Member | 2018 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2018 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Doremed Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jorma Erik Honkaniemi | Deputy Member | 0 companies |
| Nikole Harriet Honkaniemi | Board of Directors | 0 companies |